A5086580448- Gastric Cancer Management and Outcomes
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Advanced Breast Cancer Therapies
- Lymphoma Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Global Cancer Incidence and Screening
- Viral-associated cancers and disorders
- Metastasis and carcinoma case studies
- Esophageal Cancer Research and Treatment
- Multiple and Secondary Primary Cancers
- CRISPR and Genetic Engineering
- Genetic factors in colorectal cancer
- Lung Cancer Research Studies
- Parathyroid Disorders and Treatments
- Breast Cancer Treatment Studies
- Neuroendocrine Tumor Research Advances
- Pancreatic and Hepatic Oncology Research
- Cancer Genomics and Diagnostics
- Salivary Gland Tumors Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- PARP inhibition in cancer therapy
- Eosinophilic Disorders and Syndromes
- Colorectal and Anal Carcinomas
- Neutropenia and Cancer Infections
Instituto Nacional de Enfermedades Neoplásicas
2016-2025
EsSALUD
2021
279 Background: Colorectal cancer (CRC) represents the third cause of malignant neoplasm in world and second terms mortality. CRC is a major cancer-related morbidity mortality Peru. Diagnosis at younger ages challenge. In this study, we evaluated prognostic factors patients who were metastatic diagnosis or progressed to disease during follow-up. Methods: A descriptive cross-sectional between 2013 2022, 66 under 40 years old stage IV analyzed. Parameters age, gender, comorbidity, performance...
Background: Natural killer/T-cell lymphoma (NKTCL), part of T-cell and NK-cell neoplasms in the World Health Organisation (WHO) classification, is an aggressive with poor prognosis more predominantly seen Asian South American countries.This study evaluates factors associated survival among patients newly diagnosed NKTCL Peru.Methods: Information was abstracted from medical records (MR) for all >13 years age at Instituto Nacional de Enfermedades Neoplasicas (INEN) between 2002 2011.The...
Aim: FLABRA evaluated the prevalence of BRCA mutations, genetic counseling and management approaches in patients with ovarian cancer Latin America. Patients & methods: from six Latin–American countries were enrolled. Tumor samples tested for mutations (BRCAmut). In cases BRCAmut, blood analyzed to determine germline versus somatic mutations. Medical records reviewed approach treatment plan. Results: From 472 enrolled, 406 yielded conclusive results: 282 wild-type (BRCAwt), 115 BRCAmut nine...
524 Background: Hepatocellular carcinoma (HC) is the most common primary tumor of liver and a significant health problem worldwide with check-point inhibitors oral multikinase (TKI) as first-line therapy for advanced diseases. While chemotherapy treatment may not be standardized in current clinical management guidelines, it remains only available option numerous Latin American countries. Methods: A retrospective review was carried out, patients older than 18 years, between January 2011...
e23557 Background: The management of soft tissue sarcomas (STS) presents a challenge in Peru, with fragmented health system and few centers specialized sarcoma care. There is no national cancer registry, which does not allow us to have real view the most prevalent types. Our aim was determine incidence Instituto Nacional de Enfermedades Neoplásicas (INEN) know care capacity nationwide. Methods: A retrospective study carried out INEN between 2009 2015 STS. Also, survey diagnosis treatment...
Advanced breast cancer is an incurable disease, with a median overall survival of 3 years, including in countries without access problems. Although chemotherapy reserved some cases, it still used many as first-line therapy. The aim our study to evaluate the treatment choices and factors that influence therapeutic decisions. A retrospective analysis was conducted hormone receptor (+)/HER2 (−) advanced patients classified into three groups according second-line received: endocrine...
e13101 Background: Lung cancer epidemiology and survival data is lacking in LA. This information relevant for understanding regional burden designing targeted interventions control. Methods: Retrospective analysis of lung cases diagnosed at Instituto Nacional de Enfermedades Neoplasicas (INEN) from 2010 to 2014. Data was manually curated clinical files. Results: 1384 patients were included. Median age diagnosis 64 years old (range 20-92) 51.6% females. The histologic type adenocarcinoma, NOS...
Cardiac amyloidosis is a rare clinical entity and, therefore, almost unknown. It shows as restrictive cardiomyopathy, since it an infiltrative disease caused by the extracellular deposition of amyloids in cardiac wall. Although may be systemic, heart condition determines its poor prognosis. This case 38-year-old patient who was admitted for dyspnea and severe fatigue. He diagnosed with IgA multiple myeloma, lambda light chains, stage IIIB, initiated treatment cyclophosphamide, thalidomide...
686 Background: In Peru, the incidence of pancreatic tumors is 3.59 per 100,000 inhabitants, being ninth cause death. The standard treatment in world surgery, achieved 13% patients, with overall survival (OS) and disease-free (PFS) at 5 years 10% 34%, respectively. our study, different subtypes that were resected by their clinical/pathological characteristics, OS PFS evaluated. Methods: A retrospective review was carried out, patients older than 18 years, diagnosed treated first intention...
204 Background: In Peru, colon cancer is the 5th most common cause of and sixth deadly. Currently, surgery remains as only curative therapy, however, there risk recurrence. Adjuvant chemotherapy has become a useful tool to improve progression-free survival (PFS) overall (OS). this study, we determine current our stage III patients, submitted adjuvant chemotherapy, if similar evidence seen in large international studies; also, analyze delay impact on survival. Methods: This descriptive...
Introduction: Anaplastic Large T-Cell Lymphoma is an infrequent pathology, determined by the expression of CD30, with different characteristics in its presentation and being more aggressive according to ALK. Objectives: The present study seeks determine epidemiological, clinicopathological prognostic patients Lymphoma. Methods: Descriptive, retrospective diagnosed National Institute Neoplastic Diseases (INEN) between 2006 2016. Results: pathology 86 was analyzed reviewed, 57% were men 33%...